Sidley-Led Roche To Buy US Drugmaker For Up To $3.1B
Swiss pharmaceutical giant Roche said on Monday that it plans to buy Carmot Therapeutics, a developer of obesity and diabetes drugs, for up to $3.1 billion as it seeks to add weight-loss...To view the full article, register now.
Already a subscriber? Click here to view full article